Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
26 November 2018 | Story Valentino Ndaba | Photo Barend Nagel
Book Launch read more
Peace Leadership: Self-Transformation to Peace is about a kind of leadership that puts peace first.

A young democracy such as South Africa is defined by a desire for better relationships, interconnectedness, inclusivity, cohesion, justice and a shared understanding. 
Peace Leadership: Self-Transformation to Peace offers a practical framework for all leaders, as well as for the average person on the street, on how to achieve this aspiration. 

A desire for peace

“It is every human’s desire to experience peace and to facilitate that peacefulness we need peace leaders.” The book offers strategies which leaders can apply to maintain and restore peace in conflict-ridden regions such as Bosnia, according to Martha Harunavamwe of the University of the Free State’s (UFS) Department of Industrial Psychology, who contributed two chapters to the book. The text also offers peace strategies to communities outside conflict-ridden regions. 

The written work explores ways in which the 21st century leader has the power to influence a nation towards or away from peace, the possibilities of restoring relationships, as well as how social systems can be tailored in the best interest of citizens for the purpose of conflict resolution.

The building blocks

Peace Leadership: Self-Transformation to Peace is built upon a three-phase foundation. “Moving through different phases, leading self, leading with others and leading your community will enhance self-transformation to the creation of peace.” 

Through cycles of action, reflection, learning and adaptation, peace leaders will improve on efforts to obtain peace,” said one of the editors and author of seven chapters, Prof Ebben Van Zyl. These building blocks model a more civilised and flourishing world in which the financial, political, health and education, human security, and legal needs of the community are served, thus creating a peaceful society.

Prof Van Zyl who is also from the Department of Industrial Psychology, edited the book, with Dr Andrew Campbell of the International Peace and Leadership Institute in the US.

Leaders are in the eye of the beholder

Two chapters of the book were written from a governance perspective. In her contribution, Prof Liezel Lues of the UFS Department of Public Administration states that there are large communities of peace leaders, considering they encompass all those who contribute towards nation-building, be they politicians, singers, actors, or business owners.

The importance of peace leaders should never be underestimated. If anything, scholar-practitioners, educators, academics, researchers, leadership development fraternities, peace organisations, negotiators, think-tanks, the diplomatic corps, government institutions, non-governmental organisations, consultants or advisors, security companies, the private sector and trade unions, should strive to become fluent in the concepts advocated for in Peace Leadership: Self-Transformation to Peace.

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept